Search for: "KING PHARMACEUTICALS, INCORPORATED" Results 1 - 20 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Oct 2021, 5:12 pm
Cir. 2017) (explaining that “the tenth-digit statistical suffixes . . . are not statutory,” as those suffixes are not incorporated in the HTSUS’s legal text). [read post]
9 Jan 2012, 4:44 pm by Adrian Lurssen
We're pleased to welcome the following lawyers and law firms to JD Supra, now distributing their legal updates and publications on our law news network:- King & Spalding"Celebrating more than 125 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 800 lawyers in 17 offices in the United States, Europe, the Middle East and Asia. [read post]
31 Jan 2007, 8:26 pm
The Bolar exception in effect shortens the protection term of pharmaceutical and medical device patents. [read post]
18 Oct 2007, 11:00 pm
Quite right, said the CFI, dismissing Intervideo's appeal - CFI decision in Case T-105/06 Intervideo v OHIM, (IPKat)EPO adds EPC post-grant data to PRS database (EPO), EU Patent Jurisdiction: Details of New Proposals From Portuguese EU Presidency (Blog@IPR::JUR), (IAM), Teva invalidates acid metabolite patents for terfenedine, (Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc, Aventis and Sepracor [2007] EWHC 2276 (Ch) ), (IPKat), Nice summary of… [read post]
12 Apr 2013, 10:48 am by Jason Rantanen
  Because it's a grant by the King, in English history only the King could revoke the patent. [read post]
9 Apr 2015, 11:59 am by Lawrence B. Ebert
Chien, Of Trolls, Davids, Goliaths, and Kings: Narratives and Evidence in the Litigation of High-Tech Patents, 87 N.C. [read post]
12 Jun 2023, 1:09 pm by admin
 Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
2 Feb 2015, 2:20 am
For instance: when does the alteration of objects incorporating the protected work involve a new authorisation from the right holder? [read post]
15 Jan 2008, 3:06 am
OfficeMax Incorporated filed 05/01/07 1:07-cv-02532 The Ultimate Back Store, Inc. v. [read post]
2 Jan 2016, 2:51 pm by Thaddeus Mason Pope, J.D., Ph.D.
Next week, the 110th AALS Annual Meeting starts in New York. [read post]
7 Mar 2017, 3:16 am by Dennis Crouch
Sweetland, The Federal Trade Commission’s (FTC) Recommendations to the International Trade Commission (ITC):  Unsound, Unmeasured, and Unauthoritative, 2011 Patently-O Patent Law Journal 1 (levi.ftcunsound.pdf) Kevin Emerson Collins, An Initial Comment on King Pharmaceuticals: The Printed Matter Doctrine as a Structural Doctrine and Its Implications for Prometheus Laboratories, 2010 Patently-O Patent Law Journal 111 (Collins.KingPharma.pdf) Robert A. [read post]
12 Aug 2011, 6:29 am by Ed Wallis
As far back as 1994, the Department of Health & Human Services, through its Office of Inspector General (“HHS OIG”), addresses the question of when payments made to doctors-either by a hospital seeking referrals, or by a pharmaceutical company seeking prescriptions-would violated the AKA. [read post]
17 Aug 2009, 10:44 am
(Sharon, MA; Dennis Yu, President) Asign Incorporated (Clinton, MA; Arvin Sebastian, President) Assessconnect Inc. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
16 Aug 2009, 11:23 am
Specific performance against the buyer was rarely incorporated into acquisition agreements, not to mention the absence of any bank willing to agree to specific performance with respect to its obligations. [read post]